Inflammatix: Heiner Dreismann

Immune system molecular diagnostics firm Inflammatix has appointed Heiner Dreismann to its board of directors. He has more than 35 years of experience in the life sciences and healthcare industries and was the CEO of Roche Molecular Systems from 2000 to 2006. Dreismann also held leadership positions at Roche's diagnostic division, and he currently serves on the boards of several public, private, and non-profit organizations.